STOCKS TELEGRAPH

Tag: Jaguar Health Inc

  • Is JAGX Stock Up Premarket For A Reason?

    During pre-market trading on Tuesday, Jaguar Health Inc. (JAGX) climbed 2.55% to $1.61. The Jaguar Health stock finished the last trading session down -4.85% at $1.57. The price range for JAGX stock was between $1.55 and $1.65. During the past 100 days, JAGX stock traded 3.33 million shares daily but the volume of 11.44 million shares traded in the last session was much higher than that. In the past five days, JAGX shares have gained 3.29%, but have lost -17.80% over a month. We can use recent developments to provide a deeper understanding of the company as JAGX stock rose despite no current news.

    What is the latest from JAGX?

    As a commercial stage pharmaceuticals company, Jaguar Health aims to develop plant-based, non-opiod, and sustainably-derived prescription medications that are safe and effective for people and animals with GI distress, especially chronic, debilitating diarrhea. JAGX’s wholly-owned subsidiary, Napo Pharmaceuticals, Inc., is focused on the development and commercialization of plants harvested from rainforest areas for use in gastrointestinal pharmaceuticals.

    As the only oral plant-based prescription medicine approved under FDA Botanical Guidance, the Mytesi product developed by JAGX provides symptomatic relief of noninfectious diarrhea associated with HIV/AIDS in adults on antiretroviral therapy. The Napo EU S.p.A. subsidiary of Napo Pharmaceuticals aims to expand access to crofelemer in Europe.

    For the third time, Jaguar Health’s annual shareholders’ meeting on May 13 has been adjourned due to a lack of quorum.

    • Hence, the adjourned meeting of JAGX will now be held on August 6, 2021.
    • JAGX will hold its annual meeting at its San Francisco office.
    • The record date used to determine which JAGX stockholders will be eligible for the Annual Meeting was April 12, 2021.
    • The proposals have been generally well received by JAGX stockholders.
    • A JAGX stockholder who does not intend to revoke or change his or her previously delivered proxy is not required to take any action.
    • During the annual meeting, JAGX encouraged its eligible stockholders who still have not voted their shares / provided voting instructions to their broker / other record holder to do so.
    • The company counted on their participation as to reach quorum, JAGX still needs to receive votes from 2.9% of its eligible common stockholders.

    How can JAGX shareholders vote?

    There are several voting options available to Jaguar Health (JAGX) shareholders. Shareholders of JAGX can vote by internet at http://www.voteproxy.com or by phoning 800-776-9437 24 hours a day or submitting a proxy card properly executed. The street name holders of JAGX stock have the option of voting via their broker. In the process of preparing the proposals for stockholders to vote on at the Annual Meeting, JAGX has not made any changes.

  • Jaguar Health Inc. (JAGX) stock rises in the after-hour trading. Why is it so?

    Jaguar Health Inc. (JAGX) stock rises in the after-hour trading. Why is it so?

    Jaguar Health Inc. (JAGX) stock surged by 3.45% in the last trading closed as well as the JAGX stock continued to rise by 9.44% in the after-hour after Jaguar Health announced its full year 2020 financial results. Jaguar Health, the pharmaceutical company is dedicated towards developing innovative, plant-based, non-opioid, and sustainably derived pharmaceutical drugs for people and animals who are suffering from gastrointestinal distress, especially chronic, debilitating diarrhea. The Mytesi product is the only oral plant-based prescribed drug approved under FDA Botanical Guidelines for the effective treatment of noninfectious diarrhea in adults with HIV/AIDS who are on antiretroviral therapy.

    2020 Financial Results

    • For the year 2020 Mytesi net sales were around $9.3 million and Mytesi gross sales have been calculated as $20.4 million, this is an increase of 64% and 148% respectively compared to the previous year.
    • The net operating expense generated for the year 2020 was $36.0 million while it was $34.7 million for the year 2019. The operating has increased by 4% from the previous year.
    • JAGX’s total cost of product revenue was $3.3 million compared to $3.8 million from the year 2019 that means it is a decrease of 14%.
    • The General and Administrative expense was $14.4 million for the year 2020 whereas the G&A expense for the previous year was $13.5 million that means it has increased.
    • The R&D expense of JAGX stock for 2020 was $6.4 million, relative to $5.8 million in 2019, a rise of 10%, or $0.6 million, year over year. Other expenditures of $0.9 million, mostly consulting, formulation, and regulatory fees, contributed to the rise.
    • Lastly the net loss faced by JAGX stock for the year 2020 was $33.8 million which has also decreased relative to the previous year where net loss was $38.5 million.

    Other Recent Development

    On March 30, 2021, JAGX stock announced that it supports the main sponsor’s choice of investment bank and nominated advisor (“NOMAD”) for the proposed Dragon special purpose acquisition company. The Dragon SPAC plans to list on the AIM Italia exchange and merge with its named goal, Napo EU S.p.A. which is the Dragon SPAC’s Italian subsidiary.

    After the upcoming holidays, during the week of April 5th, more details on the Dragon SPAC’s banking engagement, including the Dragon SPAC’s selection of its necessary NOMAD, will be published. A NOMAD is a necessary financial services firm that will assist and help the issuer, the Dragon SPAC, in complying with Borsa Italiana’s IPO process for AIM Italia listing.

  • What changed for these 50 stocks in Pre-Market Session?

    What changed for these 50 stocks in Pre-Market Session?

    Oncternal Therapeutics Inc. (ONCT) stock soared 2.42% to $2.96 in the pre-market trading as the company raised the size of the formerly publicized offering and purchase on a firm commitment basis 7,258,065 shares of common stock of the Company, at a price to the public of $3.10 per share, less underwriting discounts, and commissions.

    JOYY Inc. (NASDAQ: YY) shares are trading up 19.13% at $87.75 at the time of writing as the Company revealed its Q3, 2020 Earnings. Analysts have a consensus price target of $125. The company’s 52-week range was noted as $41.33 to $108.21.

    Aptevo Therapeutics Inc. (APVO) grew over 38.17% at $48.9 in pre-market trading today after the firm offered an update on ALG.APV-527, a novel immunotherapeutic bispecific candidate aimed for the cure of multiple solid tumors expressing 5T4, a tumor-restricted antigen.

    Zomedica Pharmaceuticals Corp. (ZOM), a Drug Manufacturers – Specialty & Generic company, dropped about -2.19% at $0.1428 in pre-market trading Thursday as the firm announced its Q3 2020 results.

    Nxt-ID Inc. (NXTD) stock moved down -1.99 percent to $0.35 in the pre-market trading after the Corporation declared to adjourn the annual meeting of shareholders.

    MoneyGram International Inc. (MGI) lost over -7.9% at $6.7 in pre-market trading Thursday 19 November 2020, as the company posted 150% year-over-year cross-border deal and revenue growth for October in its direct-to-consumer digital business, MGO.

    Lexicon Pharmaceuticals Inc. (LXRX) is up more than 2.5% at $1.64 in pre-market hours Thursday 19 November 2020 following the company revealed to participate in Stifel 2020 Virtual Healthcare conference on Wednesday, November 18, 2020. The stock had dropped over -11.60% to $1.60 in the last trading session.

    Before the trading started on 19 November 2020, UP Fintech Holding Limited (TIGR) is up 4.61% to reach $5.9 after the Company announced to unveil its quarterly results on November 25, 2020. It has been trading in a 52-week range of $2.03 to $7.60.

    Asia Pacific Wire & Cable Corporation Limited (APWC) stock plunged -4.72% to $2.02 in the pre-market trading as the Corporation publicized that it will organize its 2020 Annual General Meeting on September 18, 2020, at 9:00 a.m. New York time at its headquarters located at Room B, 15th Floor, No. 77, Section 2, Dunhua South Road, Taipei, 106, Taiwan and (2) the Company has procured a US$6,000,000 secured loan from its majority shareholder, Pacific Electric Wire & Cable Co., Ltd.

    Marathon Patent Group Inc. (NASDAQ: MARA) shares are trading down -0.35% at $2.88 at the time of writing following Bitcoin self-mining company has disclosed a new investor presentation, which contains updated economic information as of November 5, 2020. The company’s 52-week range was noted as $0.35 to $5.25. Analysts have a consensus price target of $8.

    Futu Holdings Limited (FUTU) grew over 10.7% at $47.6 in pre-market trading today after the company publicized its 3rd quarter scores.

    L Brands Inc. (LB), and Apparel Retail company, rose about 16.04% at $39.0 in pre-market trading Thursday as the firm announced upbeat earnings results.

    Agora Inc. (API) stock moved up 2.45 percent to $35.99 in the pre-market trading after the Tech-giant announced its Q3 2020 results.

    ObsEva SA (OBSV) gained over 3.38% at $2.14 in pre-market trading Thursday 19 November 2020 as the biotech-firm declared the positive topline results of PROLONG, the Phase 2a proof-of-concept, randomized, double-blind, placebo-controlled trial of laropiprant in preterm labor.

    Bilibili Inc. (BILI) is up more than 4.49% at $50.0 in pre-market hours Thursday 19 November 2020, after the Corporation revealed its third-quarter 2020 results. The stock had dropped over -4.40% to $47.85 in the last trading session.

    Before the trading started on 19 November 2020, Youdao Inc. (DAO) is up 3.9% to reach $26.13, as it revealed quarterly results for the fiscal third quarter. It has been trading in a 52-week range of $13.20 to $47.70.

    Oragenics Inc. (OGEN) stock plunged -6.27% to $0.4377 in pre-market trading.

    SPI Energy Co. Ltd. (NASDAQ: SPI) shares are trading up 3.51% at $8.25 at the time of writing, as the Energy sector firm announced that its completely-owned SPI Solar, subsidiary completed the sale of a 1.015-megawatt solar project located on Hawaii’s Maui island. The company’s 52-week range was noted as $0.55 to $46.67.

    Gold Fields Limited (GFI) tumbled over -3.19% at $9.42 in pre-market trading today, following the Company revealed operational details for the 3-month period ending September 30, 2020.

    Marin Software Incorporated (MRIN), a Software – Application company, dropped about -3.38% at $2.0 in pre-market trading Thursday.

    X Financial (XYF) stock moved up 99.14 percent to $1.39 in the pre-market trading as the company disclosed that it will hold its 2020 annual general meeting of shareholders at its offices at 7/F, Block A, Aerospace Science and Technology Plaza, No.168 Haide Third Avenue, Nanshan District, Shenzhen, China on December 11, 2020, at 10:00 a.m., Beijing Time.

    Simon Property Group Inc. (SPG) lost over -2.43% at $74.75 in pre-market trading Thursday 19 November 2020 after the news that Simon has valued an upsized public offering of 19,250,000 shares of common stock at a public offering price of $72.50 per share that is expected to close November 23, 2020, subject to the satisfaction of customary closing conditions.

    ZoomInfo Technologies Inc. (ZI) is up more than 2.55% at $40.6 in pre-market hours Thursday 19 November 2020, as the Company revealed its Q3 2020 Earnings results. The stock had dropped over -2.85% to $39.59 in the last trading session.

    Before the trading started on 19 November 2020, Pan American Silver Corp. (PAAS) is down -2.98% to reach $29.98, after the Company Q3 results matched the predictions. It has been trading in a 52-week range of $10.61 to $40.11.

    Leap Therapeutics Inc. (LPTX) stock soared 6.67% to $1.6 in the pre-market trading, as the Company posted Q3 2020 Earnings results. The most recent rating by Piper Sandler, on June 29, 2020, is at an Overweight.

    Hudson Capital Inc. (NASDAQ: HUSN) shares are trading up 33.93% at $3.0 at the time of writing, following news of Hudson Capital Inc. and FreightHub, Inc. progressing further with the planned merger. The company’s 52-week range was noted as $1.60 to $9.80.

    Transocean Ltd. (RIG) grew over 4.07% at $1.28 in pre-market trading today, as the firm reported deep-water Corcovado, deep water Mykonos contract extensions.

    Acasti Pharma Inc. (ACST), a Biotechnology company, rose about 4.55% at $0.23 in pre-market trading Thursday, after the firm revealed Q2, 2021 fiscal results.

    Orbital Energy Group Inc. (OEG) stock moved up 3.56 percent to $0.8 in the pre-market trading, as the company posted Q3, 2020 earnings reports.

    Ideanomics Inc. (IDEX) gained over 10.34% at $1.28 in pre-market trading Thursday 19 November 2020 after the firm announced MEG October & Q4 sales activity.

    Virgin Galactic Holdings Inc. (SPCE) is up more than 2.04% at $23.05 in pre-market hours Thursday 19 November 2020 after the Analysts decreased its estimates by almost 25%. The stock had jumped over 5.81% to $22.59 in the last trading session.

    Before the trading started on 19 November 2020, Washington Prime Group Inc. (WPG) is down -2.15% to reach $0.742 after the report of the company to present at REITworld 2020 Virtual Investor Conference. It has been trading in a 52-week range of $0.49 to $4.49.

    Kintara Therapeutics Inc. (KTRA) stock soared 1.79% to $1.71 in the pre-market trading, after the company announced Q1, 2021 results and offered a business update.

    Electra Meccanica Vehicles Corp. (NASDAQ: SOLO) shares are trading up 7.53% at $7.43 at the time of writing. The company’s 52-week range was noted as $0.89 to $7.91.

    K12 Inc. (LRN) grew over 6.56% at $25.49 in pre-market trading today.

    Polar Power Inc. (POLA), an Electrical Equipment & Parts company, dropped about -3.35% at $3.46 in pre-market trading Thursday.

    Ayro Inc. (AYRO) stock moved up 3.77 percent to $4.4 in the pre-market trading, after the company revealed its Q3, 2020 fiscal results.

    Jaguar Health Inc. (JAGX) gained over 5.82% at $0.22 in pre-market trading Thursday 19 November 2020, following the announcement of its third-quarter 2020 financial scores.

    Sanchez Midstream Partners LP (SNMP) is down more than 0.0% at $0.5951 in pre-market hours Thursday 19 November 2020. The stock had jumped over 11.03% to $0.60 in the last trading session.

    Before the trading started on 19 November 2020, Waitr Holdings Inc. (WTRH) is up 6.46% to reach $3.38, as the company’s earnings results topped estimates. It has been trading in a 52-week range of $0.26 to $5.85.

    GreenPower Motor Company Inc. (GP) stock plunged -1.07% to $18.49 in the pre-market trading, after the report that Thermalito Union Elementary School District Agrees on purchase of six all-electric school buses from GreenPower. The most recent rating by Maxim Group, on November 02, 2020, is a Buy.

    Arcimoto Inc. (FUV) grew over 0.74% at $9.51 in pre-market trading today, after the company revealed its Q3, 2020 results, and business update.

    Kandi Technologies Group Inc. (KNDI), an Auto Manufacturers company, rose about 11.55% at $12.65 in pre-market trading Thursday, November 19, 2020, after the report that Kandi America’s EV qualified for $2,500 refund in Texas.

    China HGS Real Estate Inc. (HGSH) gained over 11.17% at $1.99 in pre-market trading Thursday 19 November 2020.

    VAALCO Energy Inc. (EGY) is down more than -9.63% at $1.22 in pre-market hours Thursday 19 November 2020, after the company revealed that it has signed a sale and purchase agreement to acquire Sasol Gabon S.A.’s 27.8% working interest in the Etame Marin block offshore Gabon. The stock had jumped over 32.35% to $1.35 in the last trading session.

    Before the trading started on 19 November 2020, Kazia Therapeutics Limited (KZIA) is down -7.87% to reach $12.41, as the announcement was made that it has executed a definitive contract with the International Coalition for Adaptive Research (GCAR) to commence Kazia’s participation in the GBM AGILE pivotal study in glioblastoma. It has been trading in a 52-week range of $2.47 to $11.10.

    Naked Brand Group Limited (NAKD) stock soared 39.0% to $0.18 in the pre-market trading.

    Phoenix Tree Holdings Limited (NYSE: DNK) shares are trading down -18.6% at $3.72 at the time of writing. The company’s 52-week range was noted as $1.27 to $13.90.

  • 20 Trending Stocks In Biotechnology Industry You Should Consider Buying

    20 Trending Stocks In Biotechnology Industry You Should Consider Buying

    Investors are always looking for safe and secure investments and as a strong and profitable industry, the biotechnology industry is considered to be an attractive area of investment. This industry has experienced massive growth in recent years and is continuously adopting new technological advancements to keep pace with the fast-growing market. Biotechnology is a set of tools that uses living organisms to create or change a product, improve plants, trees, or animals, or develop microorganisms for specific uses.

    Modern Biotechnology’s main focus is on medicine. The companies in this sector are involved in the development of new treatments for various complex diseases. Technology has always been at the heart of the biotechnology industry. As the new technologies emerged with the passage of time the efficiency of companies has also improved. Similarly, technological advancements have also changed the clinical trial process.

    There are various other trends that the companies are following. Let see the top 20 companies in the biotechnology industry to get a better view:

    Cassava Sciences Inc. (NASDAQ: SAVA)

    Cassava Sciences Inc. (NASDAQ: SAVA) last closed at $11.47, in a 52-week range of $1.05 to $11.25. Analysts have a consensus price target of $17.00. Cassava Sciences Inc. (SAVA) has earlier announced the results of the Phase 2b study with its drug candidate Sumifilam, in Alzheimer’s disease. The clinical study which has received the funding by the National Institutes of Health (NIH) has shown the improvement in Alzheimer’s disease. Cassava Sciences Inc. (SAVA) market cap has remained high, hitting $242.02 M at the time of writing.

    Inovio Pharmaceuticals Inc. (NASDAQ: INO)

    Inovio Pharmaceuticals Inc. (NASDAQ: INO) stock soar by 10.21% to $16.94. The most recent rating by ROTH Capital, on July 01, 2020, is at a Sell. Inovio Pharmaceuticals Inc. (INO) has revealed that the US Food and Drug Administration (FDA) has informed the company that it has some questions related to the Phase 2/3 trial of its COVID-19 vaccine candidate INO-4800, including its CELLECTRA 2000 delivery device to be used in the trial. the company said that it will halt the trial until it clear all the ambiguities of FDA.

    Sorrento Therapeutics Inc. (NASDAQ: SRNE)

    Sorrento Therapeutics Inc. (NASDAQ: SRNE) Shares headed rising, higher as much as 4.84%. The most recent rating by H.C. Wainwright, on July 31, 2020, is at a Buy. Sorrento Therapeutics Inc. (SRNE) has earlier revealed the results of its’ multicenter, open-label, Phase 1b Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for the Treatment of Intractable Cancer Pain at the 14th Annual Pain Therapeutics Summit. The company has reported the encouraging results from its Phase 1b study to evaluate Epidural Resiniferatoxin Injection.

    Vaxart Inc. (NASDAQ: VXRT)

    Vaxart Inc. (NASDAQ: VXRT) rose 7.40% after gaining more than $0.51 on Friday. Pomerantz LLP is investigating claims on behalf of investors of Vaxart, Inc. Vaxart Inc. share price went from a low point around $0.25 to briefly over $17.49 in the past 52 weeks, though shares have since pulled back to $7.40. Vaxart Inc.’s market cap has remained high, hitting $752.43 M at the time of writing.

    Novavax Inc. (NASDAQ: NVAX)

    Novavax Inc. (NASDAQ: NVAX) stock soar by 10.86% to $113.56. The most recent rating by H.C. Wainwright, on August 06, 2020, is at a Buy. Par Sterile Products, LLC (Par Sterile) has entered into a non-exclusive agreement with Novavax, Inc. to provide fill-finish manufacturing services at its plant in Rochester, Michigan for NVX-CoV2373, Novavax’ COVID-19 vaccine candidate.

    Onconova Therapeutics Inc. (NASDAQ: ONTX)

    Onconova Therapeutics Inc. (NASDAQ: ONTX) Shares headed falling, lower as much as -3.23%. The most recent rating by H.C. Wainwright, on March 01, 2018, is at a Buy. Onconova Therapeutics Inc. (ONTX) earlier revealed that it has started the Phase 1 clinical trial in China for ON 123300 by its partner, HanX Biopharmaceuticals. Onconova has partnered with HanX Biopharmaceuticals in December 2017 for the development, registration, and commercialization of ON 123300 in China.

    Jaguar Health Inc. (NASDAQ: JAGX)

    Jaguar Health Inc. (NASDAQ: JAGX) last closed at $0.31, in a 52-week range of $0.29 to $1.38. Jaguar Health Inc. (JAGX) earlier revealed itis scheduled to participate in its first “Diarrhea Dialogues” virtual event on October 20 from 3:00 PM. The event, open to the financial and business community, will discuss the importance of supportive care for cancer patients as it relates to chronic lower GI tract distress, specifically with regard to debilitating diarrhea experienced as a result of cancer therapy.

    Zogenix Inc. (NASDAQ: ZGNX)

    Zogenix Inc. (NASDAQ: ZGNX) stock drop by -1.46% to $17.50. The most recent rating by Raymond James, on August 25, 2020, is at an Mkt perform. Zogenix Inc. (ZGNX) has revealed the pricing of its offering of $200,000,000 aggregate principal amount of 2.75% convertible senior notes due 2027 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

    Trevena Inc. (NASDAQ: TRVN)

    Trevena Inc. (NASDAQ: TRVN) Shares headed rising, higher as much as 4.04%. The most recent rating by Guggenheim, on September 14, 2020, is at a Buy. Trevena Inc. (TRVN) has earlier participated in three presentations at the virtual 2020 American College of Clinical Pharmacology (ACCP) Annual Meeting. The meetings have taken place from September 21st to 23rd, 2020.

    VBI Vaccines Inc. (NASDAQ: VBIV)

    VBI Vaccines Inc. (NASDAQ: VBIV) last closed at $3.08, in a 52-week range of $0.47 to $6.93. VBI Vaccines Inc. (VBIV) is scheduled to participate in upcoming presentations including Sci-B-Vac: Results on Ph3 Hep B vaccine, Targeting CMV for the development of effective GBM immunotherapy on September 29 and 30, 2020, respectively. It has today participated in the COVID-19 panel discussion on the topic: What existing treatments and vaccine development platforms show promise to control the rate of infection and spread?

    Brickell Biotech Inc. (NASDAQ: BBI)

    Brickell Biotech Inc. (NASDAQ: BBI) Shares headed rising, higher as much as 3.90%. The most recent rating by Lake Street, on August 28, 2020, is at a Buy. Brickell Biotech Inc. (BBI) has revealed that its Japanese development partner, Kaken Pharmaceutical Co., Ltd. has received approval to manufacture and market sofpironium bromide gel, 5% under the brand name ECCLOCK in Japan for the treatment of primary axillary (underarm) hyperhidrosis.

    VYNE Therapeutics Inc. (NASDAQ: VYNE)

    VYNE Therapeutics Inc. (NASDAQ: VYNE) Shares headed falling, lower as much as -6.17%. VYNE Therapeutics Inc. (VYNE) has revealed that the Company will host a physician symposium on AMZEEQ and ZILXI™ on Thursday, October 1, 2020. VYNE market cap has remained high, hitting $271.70-M at the time of writing.

    Acorda Therapeutics Inc. (NASDAQ: ACOR)

    Acorda Therapeutics Inc. (NASDAQ: ACOR) shares were trading up 30.13% at $0.62 at the time of writing on Friday. Acorda Therapeutics Inc. (NASDAQ: ACOR) share price went from a low point around $0.42 to briefly over $3.27 in the past 52 weeks, though shares have since pulled back to $0.62. ACOR market cap has remained high, hitting $22.70M at the time of writing, giving it a price-to-sales ratio of more than 0. If we look at the recent analyst rating ACOR, H.C. Wainwright downgraded coverage on ACOR shares with a Neutral rating.

    Moderna Inc. (NASDAQ: MRNA)

    Moderna Inc. (NASDAQ: MRNA) last closed at $69.47, in a 52-week range of $13.53 to $95.21. Analysts have a consensus price target of $91.90. Moderna Inc. (MRNA) has moved up 413.45% from its 52-weeks low and moved down -327.03% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 17.30. This company’s market capitalization has remained high, hitting $25.72 billion at the time of writing.

    iBio Inc. (AMEX: IBIO)

    iBio Inc. (AMEX: IBIO) rose 7.77% after gaining more than $0.15 on Friday. iBio Inc. (IBIO) share price went from a low point around $0.05 to briefly over $7.45 in the past 52 weeks, though shares have since pulled back to $2.08. iBio Inc. has moved up 4060.00% from its 52-weeks low and moved down -72.08% from its 52-weeks high.  IBIO market cap has remained high, hitting $336.61 M at the time of writing.

    Akebia Therapeutics Inc. (NASDAQ: AKBA)

    Akebia Therapeutics Inc. (NASDAQ: AKBA) rose 0.81% after gaining more than $0.02 on Friday.  In the past 52-weeks of trading, this company’s stock has fluctuated between the low of $2.34 and a high of $13.71. It has moved up 5.98% from its 52-weeks low and moved down -8191% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 2.30. This company’s market capitalization has remained high, hitting $347.50 million at the time of writing.

    Vaccinex Inc. (NASDAQ: VCNX)

    Vaccinex Inc. (NASDAQ: VCNX) stock drop by -1.10% to $1.79. The most recent rating by BTIG Research, on September 23, 2020, is at a Neutral. Vaccinex Inc. (VCNX) share price went from a low point around $1.70 to briefly over $12.23 in the past 52 weeks, though shares have since pulled back to $1.79. VCNX has moved up 5.29% from its 52-weeks low and moved down -85.36% from its 52-weeks high.  VCNX market cap has remained high, hitting $36.19M at the time of writing.

    Ocugen Inc. (NASDAQ: OCGN)

    Ocugen Inc. (NASDAQ: OCGN) rose 2.29% after gaining more than $0.0 on Friday. In the past 52-weeks of trading, this company’s stock has fluctuated between the low of $0.17 and a high of $16.80. It has moved up 78.53% from its 52-weeks low and moved down -98.19% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 3.30. This company’s market capitalization has remained high, hitting $40.03 million at the time of writing.

    9 Meters Biopharma Inc. (NASDAQ: NMTR)

    9 Meters Biopharma Inc. (NMTR) last closed at $0.76, in a 52-week range of $0.37 to $1.22. 9 Meters Biopharma Inc. (NMTR) has moved up 106.59% from its 52-weeks low and moved down -37.33% from its 52-weeks high. Looking at its liquidity, it has a current ratio of 1.30. This company’s market capitalization has remained high, hitting $101.25 million at the time of writing.

    Clovis Oncology Inc. (NASDAQ: CLVS)

    Clovis Oncology Inc. (NASDAQ: CLVS) stock soar by 3.25% to $5.88. The most recent rating by H.C. Wainwright, on May 18, 2020, is at a Buy. Clovis Oncology Inc. (CLVS) share price went from a low point around $2.93 to briefly over $17.37 in the past 52 weeks, though shares have since pulled back to $5.88. CLVS has moved up 100.68% from its 52-weeks low and moved down -66.15% from its 52-weeks high.  CLVS market cap has remained high, hitting $502.33M at the time of writing.

     

  • Stocks to Watch Even As Markets Start the Day in the Red

    Stocks to Watch Even As Markets Start the Day in the Red

    The markets are down this morning, indicating that investors are not confident of a return to pre-pandemic levels anytime soon. Labour numbers are still pointing to a generally sluggish economy. According to a report by JOLTS, hiring was slow in July despite an increase in job openings.

    The report showed that job openings in July were still much lower when compared to a year ago. While there is an improvement when compared to March/April, they still point to a market that is still relatively depressed and does not correlate to the massive run-up in price that the stock markets have experienced recently. As such, there could still be a sizeable number of investors that believe the markets are overvalued.

    The markets have also been dampened further by news that that the Oxford vaccine trials had been halted after complications. While this is just one of the many vaccines that are being tested, it points to the massive challenges that the world faces in the race to a vaccine.

    This means that the world could have to wait longer before a credible vaccine candidate is found. By extension, this means that large segments of the economy could continue to suffer in the near-term. Despite the dampened outlook, there are stocks that are gaining quite strongly this morning. Some of the big performers this morning that are likely to outperform the markets in the day are as below.

    Yield10 Bioscience Inc [NASDAQ: YTEN]

    Yield10 Bioscience Inc is gaining strongly this morning and is currently up by over 90%. This follows the company’s announcement that its President and CEO Oliver Peoples will be presenting at the H.C Wainwright 22nd annual global investment conference that will take place between the 14th and 16th of September. The excitement around what new and exciting things he will talk about have created strong momentum that could last over the next few weeks.

    CBL& Associates Properties Inc [NYSE: CBL]

    This is another big winner this morning and is up by over 40%. This is purely a price action driven move and comes weeks after the company announced that it had entered into a debt restructuring agreement with its debt holders. Through the deal, the company aims to get rid of $1.4 billion in unsecured debt. Given the uncertainty currently prevalent in the economy, investors seem to be excited about the stock.

    Jaguar Health Inc [NASDAQ: JAGX]

    Jaguar Health Inc is up this morning and is up by over 30% pre-market. While there are no news around it this morning, the stock recently announced that it had started an initiative to develop a natural prescription medicine for treating mood disorders.